Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News The Canadian Bioceutical CBICF

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
MPX Bioceutical Corp is a Canada based company involved in the natural health products industry. It is engaged in the manufacture and distribution of nutraceuticals to the North American marketplace and providing financial and business expertise to emerging corporations primarily in the pharmaceutical, medical and biotechnology industries. The company provides management, staffing, procurement,... see more

Recent & Breaking News (GREY:CBICF)

MPX Signs Agreement With Israeli Pharmaceutical Company Panaxia for the Production and Marketing of Pharma-Grade Cannabinoid Products

GlobeNewswire January 15, 2018

MPX Enters Into Management and Option Agreements With Production Facility and Second Dispensary in Maryland

GlobeNewswire January 8, 2018

MPX Comments on Attorney General Jeff Sessions’s Memo re: Marijuana Enforcement

GlobeNewswire January 4, 2018

MPX Bioceutical Announces Beth Stavola Appointed to New Jersey Cannabis Industry Association Board of Trustees

GlobeNewswire January 3, 2018

MPX Closes Oversubscribed Private Placement Offering of $26.5 Million

GlobeNewswire December 22, 2017

MPX Bioceutical Corporation Provides Update on Private Placement

GlobeNewswire December 19, 2017

MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore Maryland

GlobeNewswire December 12, 2017

MPX Bioceutical Receives Both Municipal and State Approval for GreenMart of Nevada NLV License Transfer

GlobeNewswire December 11, 2017

MPX Bioceutical Corporation Announces $25 Million Private Placement of Units

GlobeNewswire November 30, 2017

Mpx Reports Q2 Fiscal 2018 Results

GlobeNewswire November 30, 2017

The Canadian Bioceutical Corporation Announces Name Change to MPX Bioceutical Corporation

GlobeNewswire November 2, 2017

BCC Provides Update on Health Canada Licensed Producer Application and Owen Sound Facility Build Out

GlobeNewswire October 26, 2017

BCC Announces Initial US$10 Million Drawdown on Credit Facility

GlobeNewswire October 24, 2017

BCC Announces Annual Meeting Details

GlobeNewswire October 13, 2017

BCC Signs Definitive Agreement to Expand Into Second Adult Use Market

GlobeNewswire October 13, 2017

BCC Reports Q1 Fiscal 2018 Results

GlobeNewswire September 28, 2017

BCC Provides Bi-Weekly Update on Status of Management Cease Trade Order

GlobeNewswire September 21, 2017

La Bourse des valeurs canadiennes lance l'Indice CSE25

Newsfile September 18, 2017

Canadian Securities Exchange Launches CSE25 Index

Newsfile September 18, 2017

BCC Reports Q4 and Fiscal 2017 Results

GlobeNewswire September 8, 2017